Article
Persistence of DNMT3A mutations at long-term remission in adult patients with AML.
British journal of haematology - 1 Nov 2014
Pløen Gro G, Nederby Line, Guldberg Per, Hansen Maria, Ebbesen Lene H, Jensen Uffe Birk, Hokland Peter, Aggerholm Anni
Abstract excerpt
Mutations in DNMT3A, the gene encoding DNA methyltransferase 3 alpha, have been identified as molecular drivers in acute myeloid leukaemia (AML) with possible implications for minimal residual disease monitoring and prognosis. To further explore the utility of DNMT3A mutations as biomarkers for AML, we developed assays for sensitive detection of recurrent mutations affecting residue R882. Analysis of DNA from 298...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
